Welcome to our dedicated page for Rocket Lab SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Rocket Lab's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Rocket Lab's regulatory disclosures and financial reporting.
Rocket Lab Corp director Frank Edward H. reported two bona fide gift transfers of the company’s common stock on May 29, 2026. He gifted 91,373 shares to a family trust where he serves as trustee, and a separate 91,373-share gift reduced his direct holdings to 53,613 shares. These are non-market, zero-price transfers for estate or family planning rather than open-market sales or purchases.
Rocket Lab Corp director-related entity reports stock sales. On May 28, 2026, Abalone Cove LLLP, an entity associated with director Alexander R. Slusky, sold 20,000 Rocket Lab common shares in an open-market sale at $150.0000 per share and 40,000 shares at $149.1023 per share. The weighted-average sale prices for these trades ranged from $149.0000 to $149.4100. After these transactions, Abalone Cove LLLP held 374,675 Rocket Lab common shares indirectly, while Slusky also reported 61,331 shares held directly.
Rocket Lab Corp Chief Operations Officer Frank Klein reported open-market sales of 36,860 shares of Common Stock on May 28, 2026. The shares were sold in multiple transactions at weighted-average prices ranging from $142.5900 to $150.4500, executed automatically under a Rule 10b5-1 trading plan adopted on September 19, 2025. Following these sales, Klein directly holds 1,006,987 shares of Rocket Lab common stock.
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, sold 3,500 shares of Common Stock in an open-market transaction on May 28, 2026. The weighted-average sale price was $146.6731 per share, across trades ranging from $146.60 to $146.78. After this sale, Clevenger directly holds 473,975 Rocket Lab shares.
Rocket Lab Corp reported that SVP & General Counsel Arjun Kampani sold a total of 23,804 shares of common stock in open-market transactions on May 28, 2026. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 19, 2025, at weighted-average prices ranging from $142.76 to $150.42. No derivative securities transactions were reported in this filing.
Alexander R. Slusky filed a Form 144 reporting a proposed sale of 100,000 shares of Common Stock, dated 05/12/2026. The filing shows a reported value of $11,807,636.48 and lists 578,750,990 shares outstanding with an 05/28/2026 reference.
This notice is a regulatory disclosure of an intended resale under Rule 144; it is a routine broker‑facilitated filing and does not by itself confirm completion of a sale or the method of sale.
Rocket Lab Corp Chief Financial Officer Adam C. Spice reported open-market sales of 62,744 shares of Common Stock on May 26, 2026. The shares were sold in multiple trades at weighted-average prices ranging from $138.7700 to $144.7600 per share.
According to the disclosure, these transactions were executed as a sell-to-cover arrangement under a pre-established Rule 10b5-1 election to satisfy tax withholding obligations tied to vesting and settlement of previously granted restricted stock units. Following the sales, Spice directly holds 983,049 shares and indirectly holds 250,000 shares through a trust.
Rocket Lab Corp director and CEO Peter Beck reported an indirect conversion by a family trust associated with him. On May 26, 2026, the Equatorial Trust converted 5,000,000 shares of Series A Convertible Participating Preferred Stock into 5,000,000 shares of Common Stock at a stated price of $0.0000 per share, held indirectly "by Trust."
The filing notes that the Trust made this optional conversion to satisfy delivery of Common Stock for sales to be made in future months under a Rule 10b5-1 Plan adopted on March 27, 2026, indicating the sales are pre-planned. After the transaction, the Trust still holds 40,951,250 shares of the preferred stock and 5,000,000 shares of Common Stock indirectly, while Beck also holds 491,930 shares of Common Stock directly. The filing states that Beck disclaims beneficial ownership of the Trust-held securities except to the extent of his pecuniary interest.
Rocket Lab Corp Chief Operations Officer Frank Klein sold 44,390 shares of common stock in open-market transactions on May 26, 2026. The filing states these sales were part of a Rule 10b5-1 “sell-to-cover” plan to satisfy tax withholding from vested restricted stock units, and he continues to hold more than 1 million shares afterward.
Rocket Lab Corp senior vice president and general counsel Arjun Kampani reported open-market sales of company common stock to cover taxes tied to equity compensation. He sold a total of 98,668 shares on May 26–27, 2026 pursuant to a pre-arranged Rule 10b5-1 "sell-to-cover" election for tax withholding on vested restricted stock units. Trade prices were reported as weighted-average figures for multiple executions, including $150.0000 and $139.4122 per share. Following these transactions, Kampani directly holds 376,509 shares of Rocket Lab common stock.